v1
Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study).
Identifier:nobleid.org/w1/20260526/DFAD6A63
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260526/DFAD6A63)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims